Data on the efficacy of routinely used tumour necrosis factor‐α (TNFα) antagonists to induce and maintain minimal disease activity and remission in clinical practice are scarce [1–4]. The aim of th...
No takes yet. Share an insight, caveat, or question.
Østergaard et al. (2007) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: